International Journal of Urology

Papers
(The H4-Index of International Journal of Urology is 19. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-04-01 to 2024-04-01.)
ArticleCitations
Clinical guidelines for interstitial cystitis/bladder pain syndrome118
Interstitial cystitis/bladder pain syndrome: The evolving landscape, animal models and future perspectives91
Clinical Practice Guidelines for Bladder Cancer 2019 update by the Japanese Urological Association: Summary of the revision62
Epigenetic modifications in prostate cancer46
Gut microbiome and prostate cancer35
Endoscopic lithotripsy with a SuperPulsed thulium‐fiber laser for ureteral stones: A single‐center experience33
Combination therapy with melatonin, stem cells and extracellular vesicles is effective in limiting renal ischemia–reperfusion injury in a rat model30
Peyronie’s disease: Contemporary evaluation and management29
Expanding the limits of nephron‐sparing surgery: Surgical technique and mid‐term outcomes of purely off‐clamp robotic partial nephrectomy for totally endophytic renal tumors27
Guidelines for the medical management of pediatric vesicoureteral reflux26
Geriatric 8 screening of frailty in patients with prostate cancer26
Robot‐assisted partial nephrectomy versus standard laparoscopic partial nephrectomy for renal hilar tumor: A prospective multi‐institutional study24
Efficacy and safety of intravesical instillation of KRP‐116D (50% dimethyl sulfoxide solution) for interstitial cystitis/bladder pain syndrome in Japanese patients: A multicenter, randomized, double‐b24
Hinotori Surgical Robot System, a novel robot‐assisted surgical platform: Preclinical and clinical evaluation23
Retroperitoneal tumors: Review of diagnosis and management23
Life expectancy in metastatic prostate cancer patients according to racial/ethnic groups22
Testicular cancer and YouTube: What do you expect from a social media platform?21
Management and treatment options when facing malignant ureteral obstruction21
Efficacy and safety of first‐line nivolumab plus ipilimumab in patients with metastatic renal cell carcinoma: A multicenter retrospective study19
Considerations for the use of gonadotropin‐releasing hormone agonists and antagonists in patients with prostate cancer19
0.065546035766602